Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New navigation/help links were added to guide eligibility, contact, reading the study record, common questions, and how to join; the Intervention/Treatment header formatting was updated, and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T13:43:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous v3.5.4 in the page footer, indicating a minor version update. This change appears to be a backend or CMS update and does not affect the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-05T10:10:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3, indicating an administrative update to the page. The change does not alter the study details or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-14T22:34:21.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.2 to v3.5.3, indicating a newer release version of the page.
    Difference
    0.1%
    Check dated 2026-04-30T18:06:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:54:52.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No visible changes to the Study Details page content or layout.
    Difference
    0.1%
    Check dated 2026-03-18T18:14:12.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.